Company: OSRH
Filing Date: 2025-04-22
Form Type: 10-K
Source: 0001213900-25-034116
Chunk: 853

Company: OSR Holdings, Inc.
Filing Date: 2025-04-22
Form: 10-K
Item: Item 2
Chunk 853
---
    Shares Available
    As of the filing date, a total of 6,300,000 shares remained available for issuance under the Omnibus Plan.

    Future Considerations
    The Company may consider issuing equity-based awards in future periods as part of its strategy to attract and retain key personnel.

The Omnibus Plan is intended to (i) provide eligible individuals
with an incentive to contribute to the Company’s success and to operate and manage the Company’s business in a manner that
provides for long-term growth and profitability and that benefits stockholders and other important stakeholders, including Company
employees and customers, and (ii) provide a means of recruiting, rewarding, and retaining key personnel.

Equity awards may be granted under the Omnibus Plan to officers, directors,
including non-employee directors, other employees, advisors, consultants or other service providers of the Company or the Company’s
subsidiaries or other affiliates, and to any other individuals who are approved by the Committee (as defined below) as eligible to participate
in the Omnibus Plan. As of January 29, 2025, there are 26 employees or directors that are eligible to participate in the Omnibus
Plan, but we expect that 17 employees, including each of the Company’s named executive officers, and approximately 9 non-employee directors,
consultants, and advisors of the Company will be eligible to participate in the Omnibus Plan after the consummation of the Business Combination.
Only the Company’s employees or employees of the Company’s corporate subsidiaries are eligible to receive incentive stock
options.

104

The Omnibus Plan became effective on January 29, 2025, the date it
was adopted by the Company Board (the “Effective Date”). The Omnibus Plan will terminate automatically at 11:59PM ET on the day
before the tenth (10th) anniversary of the Effective Date unless earlier terminated by the Board or in accordance with the
terms of the Omnibus Plan.

Changes in Control 

None.

Item 13.	 Certain Relationships and Related Transactions,
and Director Independence 

On July 30, 2020, we issued an aggregate of 1,437,500 founder
shares to our Sponsor for an aggregate purchase price of $25,000 in cash, or approximately $0.017 per share. On April 25, 2022, we
executed a stock split, resulting in an aggregate of 1,725,000 founder shares held by